vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
LiveRamp Holdings, Inc. is the larger business by last-quarter revenue ($212.2M vs $151.7M, roughly 1.4× Nutex Health, Inc.). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs 7.8%, a 11.0% gap on every dollar of revenue. On growth, LiveRamp Holdings, Inc. posted the faster year-over-year revenue change (8.6% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 11.1%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
NUTX vs RAMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $212.2M |
| Net Profit | $11.8M | $39.9M |
| Gross Margin | 30.4% | 71.9% |
| Operating Margin | 20.4% | 18.6% |
| Net Margin | 7.8% | 18.8% |
| Revenue YoY | -41.1% | 8.6% |
| Net Profit YoY | -80.8% | 255.7% |
| EPS (diluted) | $2.34 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $212.2M | ||
| Q3 25 | $267.8M | $199.8M | ||
| Q2 25 | $244.0M | $194.8M | ||
| Q1 25 | $211.8M | $188.7M | ||
| Q4 24 | $257.6M | $195.4M | ||
| Q3 24 | $78.8M | $185.5M | ||
| Q2 24 | $76.1M | $176.0M | ||
| Q1 24 | $67.5M | $171.9M |
| Q4 25 | $11.8M | $39.9M | ||
| Q3 25 | $55.4M | $27.4M | ||
| Q2 25 | $-17.7M | $7.7M | ||
| Q1 25 | $21.2M | $-6.3M | ||
| Q4 24 | $61.6M | $11.2M | ||
| Q3 24 | $-8.8M | $1.7M | ||
| Q2 24 | $-364.0K | $-7.5M | ||
| Q1 24 | $-364.0K | $-5.4M |
| Q4 25 | 30.4% | 71.9% | ||
| Q3 25 | 57.8% | 70.2% | ||
| Q2 25 | 51.2% | 70.1% | ||
| Q1 25 | 55.9% | 69.3% | ||
| Q4 24 | 55.0% | 71.9% | ||
| Q3 24 | 27.8% | 72.4% | ||
| Q2 24 | 29.7% | 70.6% | ||
| Q1 24 | 15.1% | 72.2% |
| Q4 25 | 20.4% | 18.6% | ||
| Q3 25 | 48.7% | 10.7% | ||
| Q2 25 | 13.8% | 3.7% | ||
| Q1 25 | 38.1% | -6.1% | ||
| Q4 24 | 44.4% | 7.5% | ||
| Q3 24 | 12.3% | 4.0% | ||
| Q2 24 | 7.0% | -3.0% | ||
| Q1 24 | 2.1% | -8.3% |
| Q4 25 | 7.8% | 18.8% | ||
| Q3 25 | 20.7% | 13.7% | ||
| Q2 25 | -7.3% | 4.0% | ||
| Q1 25 | 10.0% | -3.3% | ||
| Q4 24 | 23.9% | 5.7% | ||
| Q3 24 | -11.2% | 0.9% | ||
| Q2 24 | -0.5% | -4.3% | ||
| Q1 24 | -0.5% | -3.1% |
| Q4 25 | $2.34 | $0.62 | ||
| Q3 25 | $7.76 | $0.42 | ||
| Q2 25 | $-2.95 | $0.12 | ||
| Q1 25 | $3.33 | $-0.10 | ||
| Q4 24 | $11.56 | $0.17 | ||
| Q3 24 | $-1.72 | $0.03 | ||
| Q2 24 | $-0.07 | $-0.11 | ||
| Q1 24 | $-0.08 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $403.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $962.3M |
| Total Assets | $918.5M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $403.4M | ||
| Q3 25 | $166.0M | $376.9M | ||
| Q2 25 | $96.7M | $371.1M | ||
| Q1 25 | $84.7M | $420.8M | ||
| Q4 24 | $40.6M | $384.3M | ||
| Q3 24 | $46.9M | $348.4M | ||
| Q2 24 | $40.8M | $342.7M | ||
| Q1 24 | $30.0M | $368.9M |
| Q4 25 | $329.4M | $962.3M | ||
| Q3 25 | $317.2M | $943.8M | ||
| Q2 25 | $235.3M | $947.8M | ||
| Q1 25 | $176.9M | $948.9M | ||
| Q4 24 | $132.4M | $957.7M | ||
| Q3 24 | $60.4M | $932.1M | ||
| Q2 24 | $62.7M | $951.9M | ||
| Q1 24 | $63.0M | $949.1M |
| Q4 25 | $918.5M | $1.3B | ||
| Q3 25 | $964.5M | $1.2B | ||
| Q2 25 | $841.0M | $1.2B | ||
| Q1 25 | $761.9M | $1.3B | ||
| Q4 24 | $655.3M | $1.3B | ||
| Q3 24 | $438.5M | $1.2B | ||
| Q2 24 | $422.4M | $1.2B | ||
| Q1 24 | $404.3M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | — |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | — | ||
| Q3 25 | $99.5M | $57.4M | ||
| Q2 25 | $27.3M | $-15.8M | ||
| Q1 25 | $51.0M | — | ||
| Q4 24 | $54.0K | $45.1M | ||
| Q3 24 | $6.8M | $55.6M | ||
| Q2 24 | $13.3M | $-9.3M | ||
| Q1 24 | $3.1M | — |
| Q4 25 | $69.0M | — | ||
| Q3 25 | $99.2M | $56.8M | ||
| Q2 25 | $26.5M | $-16.2M | ||
| Q1 25 | $50.9M | — | ||
| Q4 24 | $-341.0K | $44.8M | ||
| Q3 24 | $6.2M | $55.4M | ||
| Q2 24 | $12.7M | $-9.6M | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 45.5% | — | ||
| Q3 25 | 37.0% | 28.4% | ||
| Q2 25 | 10.9% | -8.3% | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | -0.1% | 22.9% | ||
| Q3 24 | 7.8% | 29.8% | ||
| Q2 24 | 16.7% | -5.4% | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 0.9% | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.8% | 0.1% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 1.1% | 1.0% |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
RAMP
Segment breakdown not available.
